Literature DB >> 23531479

Regulatory T cells contribute to rosuvastatin-induced cardioprotection against ischemia-reperfusion injury.

Dan Ke1, Jun Fang, Lin Fan, Zhaoyang Chen, Lianglong Chen.   

Abstract

OBJECTIVES: CD4CD25 regulatory T cells (Tregs) play a key role in the prevention of various inflammatory and autoimmune disorders by suppressing immune responses. The beneficial effect of statins on myocardial ischemia-reperfusion injury (IRI) depends in part on their immunomodulatory and anti-inflammatory mechanisms. We aimed to determine whether Tregs contribute to statin-induced cardioprotection against myocardial IRI.
METHODS: Thirty-two rats were divided into four groups: sham, ischemia-reperfusion (IR), rosuvastatin (RSV)/IR, and mevalonic acid (MVA)+RSV/IR. Myocardial IR was induced by a 30-min coronary occlusion, followed by a 48-h reperfusion. RSV (5 mg/kg) was administered intravenously 18 h before IR. The rats were killed after 48-h reperfusion. Serum cardiac troponin I (cTnI) was measured by ELISA, infiltration of inflammatory cells in myocardium by hematoxylin and eosin staining, expression of FoxP3 protein by western blotting, accumulation of Tregs in myocardium by immunohistochemical examination, and infarct size by TTC staining.
RESULTS: Significant elevation in serum cTnI, enlarged infarct size, and marked infiltration of inflammatory cells in myocardium were observed in the IR group. The administration of RSV significantly reduced the serum cTnI level, attenuated the accumulation of inflammatory cells, decreased infarct size, and increased the FoxP3 expression and Treg accumulation in myocardium compared with the IR group. The combination of RSV and MVA pretreatment partially abolished the anti-inflammatory and infarct size-limiting effects and completely reversed Treg accumulation in myocardium induced by RSV. The accumulation of inflammatory cells was negatively correlated with FoxP3 expression and Treg accumulation in the ischemic myocardium.
CONCLUSION: RSV pretreatment was associated with more Treg accumulation, less inflammatory response, and myocardial injury, suggesting that such cardioprotection against IRI was partially mediated by Treg-negative modulation of inflammation response, probably through the HMG-CoA reductase pathway.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23531479     DOI: 10.1097/MCA.0b013e3283608c12

Source DB:  PubMed          Journal:  Coron Artery Dis        ISSN: 0954-6928            Impact factor:   1.439


  20 in total

Review 1.  Regulatory T cells in AKI.

Authors:  Gilbert R Kinsey; Rahul Sharma; Mark D Okusa
Journal:  J Am Soc Nephrol       Date:  2013-10-17       Impact factor: 10.121

Review 2.  T-cell recruitment to the heart: friendly guests or unwelcome visitors?

Authors:  Robert M Blanton; Francisco J Carrillo-Salinas; Pilar Alcaide
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-05-10       Impact factor: 4.733

3.  Atorvastatin Modulates Regulatory T Cells and Attenuates Cerebral Damage in a Model of Transient Middle Cerebral Artery Occlusion in Rats.

Authors:  Ana Lucía Rodríguez-Perea; Johanna Gutierrez-Vargas; Gloria Patricia Cardona-Gómez; Carlos Julio Montoya Guarin; Mauricio Rojas; Paula Andrea Velilla Hernández
Journal:  J Neuroimmune Pharmacol       Date:  2016-09-10       Impact factor: 4.147

4.  Effects of rosuvastatin on ADMA, rhokinase, NADPH oxidase, caveolin-1, hsp 90 and NFkB levels in a rat model of myocardial ischaemia-reperfusion.

Authors:  Oktay Burma; Elif Onat; Ayhan Uysal; Necip Ilhan; Deniz Erol; Mete Ozcan; Engin Sahna
Journal:  Cardiovasc J Afr       Date:  2014 Sep-Oct       Impact factor: 1.167

5.  Postconditioning with simvastatin decreases myocardial injury in rats following acute myocardial ischemia.

Authors:  Heng-Chen Yao; Lan-Ju Yang; Qian-Feng Han; Lan-Hua Wang; Lei Wu; Chun-Yan Zhang; Ke-Li Tian; Mei Zhang
Journal:  Exp Ther Med       Date:  2015-02-06       Impact factor: 2.447

6.  Increase of Frequency and Modulation of Phenotype of Regulatory T Cells by Atorvastatin Is Associated with Decreased Lung Inflammatory Cell Infiltration in a Murine Model of Acute Allergic Asthma.

Authors:  Yurany Blanquiceth; Ana Lucia Rodríguez-Perea; Jorge H Tabares Guevara; Luis Alfonso Correa; María Dulfary Sánchez; José Robinson Ramírez-Pineda; Paula Andrea Velilla
Journal:  Front Immunol       Date:  2016-12-21       Impact factor: 7.561

7.  Association of lymphocyte-to-monocyte ratio with in-hospital and long-term major adverse cardiac and cerebrovascular events in patients with ST-elevated myocardial infarction.

Authors:  Qian Wang; Junfen Ma; Zhiyun Jiang; Fan Wu; Jiedan Ping; Liang Ming
Journal:  Medicine (Baltimore)       Date:  2017-08       Impact factor: 1.889

8.  Postconditioning with rosuvastatin reduces myocardial ischemia-reperfusion injury by inhibiting high mobility group box 1 protein expression.

Authors:  Xianjin DU; Xiaorong Hu; Jie Wei
Journal:  Exp Ther Med       Date:  2013-10-24       Impact factor: 2.447

Review 9.  Statins as modulators of regulatory T-cell biology.

Authors:  David A Forero-Peña; Fredy R S Gutierrez
Journal:  Mediators Inflamm       Date:  2013-10-03       Impact factor: 4.711

10.  Neither T-helper type 2 nor Foxp3+ regulatory T cells are necessary for therapeutic benefit of atorvastatin in treatment of central nervous system autoimmunity.

Authors:  Martin S Weber; Thomas Prod'homme; Sawsan Youssef; Shannon E Dunn; Lawrence Steinman; Scott S Zamvil
Journal:  J Neuroinflammation       Date:  2014-02-06       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.